FeaturesSignalPricingFounders
Log inGet started free
VC

Venture Capital Fund of New England

Venture CapitalActive

The Venture Capital Fund of New England's investment activities are characterized by: - A focus on early stage companies - A geographic

Wellesley, United StatesFounded 2012vcfne.com
34
Investments
6
Exits
$10.6B
AUM
17.6%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Venture Capital Fund of New England.

Get started free

Investment Thesis & Strategy

Venture Capital Fund of New England invests in early-stage companies across advertising/marketing, financial exchanges, and fintech. They seek to invest in companies based in New England.

Investment Activity

Deals per year over the last 12 years

1
2004
2
2005
1
2006
4
2007
2
2008
0
2009
0
2010
0
2011
0
2012
0
2013
0
2014
1
2015

Portfolio Companies

Selected investments from their portfolio of 34 companies

E
Enanta Pharmaceuticals
Biotech · Series A, 0
Active
S
Solid Biosciences
Biotech · Series A, 2015
Active
C
Celladon
Biotech · Series A, 2008
Active
C
Catabasis Pharmaceuticals
Biotech · Series A, 2008
Active
M
MicroCHIPS
Biotech · Series A, 2007
Active
E
Epizyme
Biotech · Series A, 2007
Active
T
Tetraphase Pharmaceuticals
Biotech · Series A, 2007
Active
C
Civitas Therapeutics
Biotech · Series A, 2007
Active
C
Concert Pharmaceuticals
Biotech · Series A, 2006
Active
R
Rapid Micro Biosystems
Biotech · Growth, 2005
Active
I
InVivo Therapeutics
Biotech · Series A, 2005
Active
R
Radius Health
Biotech · Series A, 2004
Active

Frequently Asked Questions

Venture Capital Fund of New England focuses on Series A, Series B, Series C+ stage investments.

Related Investors